Haycock G B, Al-Dahhan J, Mak R H, Chantler C
Arch Dis Child. 1982 Dec;57(12):934-9. doi: 10.1136/adc.57.12.934.
Three children with nephropathic cystinosis were treated with indomethacin 3 mg/kg a day for periods ranging from 9 to 18 months. The drug produced worthwhile clinical improvement in all, with marked beneficial effects on polyuria, polydipsia, and general wellbeing. Clearance studies performed under conditions of maximal water diuresis showed that proximal tubular sodium reabsorption was increased in all children, with consequent reduction in sodium delivery to the distal nephron leading to reduced free water clearance and distal tubular cation exchange. Plasma sodium and potassium concentrations became normal in all patients, with improvement in phosphate and bicarbonate concentrations in one. Renal function continued to deteriorate, but without obvious acceleration of the process by the drug. We were unable to demonstrate a beneficial effect on growth; nevertheless, indomethacin is a useful adjunct to the symptomatic treatment of children with severe nephropathic cystinosis.
三名患有肾病型胱氨酸病的儿童接受了吲哚美辛治疗,剂量为每日3毫克/千克,疗程为9至18个月。该药物在所有患儿中均产生了显著的临床改善,对多尿、烦渴和总体健康状况有明显的有益影响。在最大水利尿条件下进行的清除率研究表明,所有患儿近端肾小管钠重吸收均增加,从而减少了向远端肾单位输送的钠,导致自由水清除率降低和远端肾小管阳离子交换减少。所有患者的血浆钠和钾浓度均恢复正常,其中一名患者的磷酸盐和碳酸氢盐浓度有所改善。肾功能继续恶化,但该药物并未明显加速这一进程。我们未能证明其对生长有有益作用;尽管如此,吲哚美辛仍是重症肾病型胱氨酸病患儿对症治疗的有用辅助药物。